AVACEN Treatment Method and Postprandial Blood Glucose

Completed · Not applicable · Has a placebo group

Conditions studied: Postprandial Hyperglycemia

In brief

A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on postprandial blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vacuum were also used. Each subject will use each of these three devices during the first hour of a 2-hour oral glucose tolerance test on separate visits. Subjects arrived in the morning following an overnight fast. Fasting blood glucose, blood pressure, tympanic temperature, and subjective thermal ratings were measured before and throughout the 2-hour oral glucose tolerance test.

Key facts

Study ID

NCT04018976

Run by

San Diego State University

People needed

13

Starts

2019-05-05

Expected to finish

2019-09-15

Last updated by the study team

2019-10-29

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy individuals

You may not qualify if…

• Diagnosis of diabetes, diabetes medication, hypertension medication

Where it is running

• Jeff Moore — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.